French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
Conditions: Pancreatic Cancer Resectable; Pancreatic Ductal Adenocarcinoma; Minimal Residual Disease; Liquid Biopsy; ctDNA Interventions: Biological: Blood sample/Liquid Biopsy Sponsors: University Hospital, Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia
Conditions: Colorectal Cancer; Image; Low Grade Dysplasia of Colon Interventions: Drug: SGM-101 Sponsors: Leiden University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
The HistoSonics Edison ™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
Conditions: Pancreas Cancer; Adenocarcinoma of the Pancreas; Pancreatic Cancer; Tumor of Pancreas Interventions: Device: HistoSonics Edison ™ System for the treatment of pancreatic adenocarcinoma using histotripsy Sponsors: HistoSonics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma
Conditions: Locally Advanced or Metastatic Small Bowel Adenocarcinoma Interventions: Drug: modified FOLFORINOX; Drug: Modified FOLFOX Sponsors: Centre Hospitalier Universitaire Dijon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma
Conditions: 18F-FAPI; Pancreas Adenocarcinoma; Systemic Treatment; Pathologic Response Interventions: Diagnostic Test: 18F-FAPI PET/CT Sponsors: Zhejiang University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Postoperative Morbidity and Mortality After Gastric Cancer Surgery
Conditions: Gastric Cancer; Siewert Type III Adenocarcinoma of Esophagogastric Junction; Stomach Cancer Interventions: Procedure: Elective Surgery for gastric cancer Sponsors: P. Herzen Moscow Oncology Research Institute; National Medical Research Radiological Centre of the Ministry of Health of Russia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
The LINFU ® U.S. Registry for the in the General Population Without Risk Factors
Conditions: Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma; Pancreatic Dysplasia Interventions: Diagnostic Test: LINFU ® Sponsors: Adenocyte, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery
Conditions: Esophageal Cancer; Oesophageal Cancer; Siewert Type I Adenocarcinoma of Esophagogastric Junction; Siewert Type III Adenocarcinoma of Esophagogastric Junction Interventions: Procedure: Elective Surgery for gastric cancer Sponsors: P. Herzen Moscow Oncology Research Institute; National Medical Research Radiological Centre of the Ministry of Health of Russia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
A Study on the Safety and Efficacy of the Combination of Candenizumab, Lenvatinib, and SOX Regimen in the Treatment of HER2 Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Patients
Conditions: Overall Response Rate Interventions: Drug: Combination of Cardonizumab with Lenvatinib and SOX regimen Sponsors: Fujian Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Conditions: Endometrial Cancer Stage I; Mmr Deficiency; Endometrioid Endometrial Adenocarcinoma; Immune-related Adverse Event Interventions: Drug: Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI] Sponsors: Queensland Centre for Gynaecological Cancer; GlaxoSmithKline Research& Development Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma; Esophageal Cancer Interventions: Other: Prehabilitation program Sponsors: GERCOR - Multidisciplinary Oncology Cooperative Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Early-Onset Colorectal Cancer Recurrence
Conditions: Colorectal Cancer Recurrent; Colorectal Cancer; Colorectal Neoplasms; Colorectal Adenocarcinoma; Colorectal Cancer Stage I; Colorectal Cancer Stage II; Colorectal Cancer Stage III Interventions: Other: ENCORE Sponsors: City of Hope Medical Center; IRCCS San Raffaele Hospital, Milan, Italy; Institute of Biomedical Research of Salamanca, Salamanca, Spain Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy
Conditions: Locally Advanced Pancreatic Adenocarcinoma Interventions: Radiation: MR guided radiotherapy Sponsors: UMC Utrecht; Amsterdam UMC, location VUmc; Radboud University Medical Center; Catharina Ziekenhuis Eindhoven; Centre for Human Drug Research, Netherlands; Dutch Pancreatic Cancer Group (DPCG) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma
Conditions: Rectal Adenocarcinoma Interventions: Drug: Adebrelimab; Drug: Oxaliplatin; Drug: Capecitabine; Radiation: Short-course Radiation; Procedure: Biopsy Sponsors: Sir Run Run Shaw Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Conditions: Advanced Pancreatic Adenocarcinoma Interventions: Drug: Y101D Sponsors: Wuhan YZY Biopharma Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
